Search

everythinglearnresearchcommunity

for

Search:↓

A new liposomal system for applying dutasteride to the skin was developed, showing better skin absorption and stability, potentially improving treatment for hair loss.

Hormone therapy with estradiol and spironolactone can regrow scalp hair in transgender women by lowering testosterone to female levels.

Spironolactone may be a better acne treatment for adult women than antibiotics.

Using 5-butylpicolinate esters improves the sensitivity and reliability of detecting testosterone and dihydrotestosterone in saliva.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Topical estrogen treatments did not change hair growth in certain mouse strains, questioning previous findings on their role in hair growth control.

Minoxidil, a hair loss treatment, works better and has fewer side effects when put into tiny particles called transethosomes, especially those containing oleic acid.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

Estrogens can improve skin aging but carry risks; more research is needed on safer treatments.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

The formulation with oleic acid may be better for treating male pattern baldness.

Properly administered testosterone therapy is safe and effective but often not covered by insurance.

Higher DHEA-S levels are linked to smaller ovarian volume in women with PCOS.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

Nanoethosomes can improve the skin penetration of Lidocaine for topical use.

The finasteride nanosystem with trehalose is stable and effective for topical hair loss treatment.

Ethosomes improve finasteride delivery through skin for hair loss treatment.

Researchers had trouble finding enough participants for a trial on DHEA's effects on postmenopausal women's sexual desire.

Women with acne have lower levels of a specific hormone marker than women without acne.

Women with hyperandrogenism have higher androgen levels and lower SHBG, which may contribute to conditions like excessive hair growth and early puberty.

17β-Estradiol slows wound healing in male mice through estrogen receptor-α.

Low-dose methotrexate, combined with surgical and local treatments, effectively treats severe vulvovaginal lichen planus.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Epinephrine injections can cause severe skin reactions like hair loss and necrosis.

Hormone Replacement Therapy improves skin health in postmenopausal women by boosting collagen and hydration.

Higher estrone-to-estradiol ratios are linked to worse glucose metabolism and insulin resistance in women with PCOS.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

TheDES improve drug delivery through the skin but need more safety checks.